RCEL

Insider trade Purchase by O'Toole David D (CFO)

12d ago

Insider trade Purchase by O'Toole David D (CFO)

13d ago

News Avita Medical (RCEL) Q2 Sales Up 21%

14d ago

News Avita reaffirms $80M-$85M 2026 revenue guidance as RECELL reimbursement normalizes and Cohealyx data targets faster graft readiness

18d ago

SEC filing RCEL Appoints Cary Vance CEO, Jan Stern Reed Chair, $12M Revenue, +15% YoY Growth

31d ago

News AVITA Medical appoints Cary Vance as permanent CEO

33d ago

News AVITA Medical rises as Cohealyx halves time to skin grafting

49d ago

News AVITA Medical wins BARDA contract worth up to $25.5M

54d ago

Insider trade Purchase by David D O'Toole (CFO)

98d ago

Earnings Results Earnings Results

104d ago

News Avita Medical outlines 2026 revenue target of $80M-$85M as reimbursement clarity supports multiproduct utilization

109d ago

News AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

153d ago

News MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders

153d ago